NOLAN SEAN P. purchased 40.7% of their position (444.44K shares) of TAYSHA GENE THERAPIES, INC. on the open market
Open‑market purchase worth $400.0K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 8/16/2023ACC: 0001209191-23-046150
+444.44K
Net shares
Net buyer
$400.0K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
444.44K acquired
Non-Derivative Transactions1
Common Stock
Indirect
Shares
+444.44K
Price / share
$0.90
Trade value
$400K
% of position
40.7%
8/16/2023
1.09M→1.54M
Total
Net shares
+444.44K
Net value
$400K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 8/16/2023 | P · Purchase | +444.44K | $0.90 | $400K | 40.7% | 1.09M | 1.54M |
| Total | +444.44K | $400K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
DirectShares owned1.17K
Total
1.17K direct1.17K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.17K | Direct |
| Total | 1.17K | 1.17K direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported